Trevo proview

Manufactured by Stryker

Sourced in Canada

The Trevo Proview is a compact and versatile lab equipment designed for various applications. It provides a reliable and efficient solution for tasks requiring precise temperature control and monitoring. The core function of the Trevo Proview is to maintain and regulate temperature with accuracy and consistency.

Automatically generated - may contain errors

Lab products found in correlation

Solitaire ab fr, by Medtronic (3 mentions)

6 protocols using trevo proview

Mechanical Thrombectomy for Stroke: Heparinization Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols

All eligible patients underwent MT immediately after indication assessment according to current guidelines of endovascular treatment (9 (link)). All subjects who underwent MT employed stent retriever (Solitaire AB/FR, Covidien/ev3, Irvine, CA; Trevo Proview, Stryker, CA), aspiration device (Penumbra, Alameda, CA) as the first recanalization option according to protocol. For MT failed cases, additional thrombectomy attempts and alternative rescue therapies were adopted at the discretion of the operator both for the heparinization and non-heparinization group, including intra-arterial/intravenous tirofiban administration, intra-arterial thrombolysis, balloon angioplasty, and emergent stenting.
Heparinization during MT was performed empirically per individual operator's discretion according to local protocols. Heparinization was defined as intravenous administration of unfractionated heparin, being infused at 50–100 IU/Kg at first and additional 1,000 IU at intervals of an hour during the operation (11 (link), 12 (link)). Oral antiplatelet therapy (aspirin100 mg or clopidogrel 75 mg once daily) or dual antiplatelet therapy were given according to head CT 24 h post-MT as a routine according to local protocols. All intraprocedural details were digitally documented for further analysis.

Yang M., Huo X., Gao F., Wang A., Ma N., Liebeskind D.S., Wang Y, & Miao Z. (2019). Safety and Efficacy of Heparinization During Mechanical Thrombectomy in Acute Ischemic Stroke. Frontiers in Neurology, 10, 299.

+ Open protocol

+ Expand

Retrospective Analysis of Anterior Circulation Thrombectomy

Check if the same lab product or an alternative is used in the 5 most similar protocols

This is a retrospective analyzing consecutive patients with anterior circulation occlusion who underwent mechanical thrombectomy between January 2016 and February 2022. We included patients based on the following criteria: (1) patients who underwent MT employing second-generation stent-retriever devices (Solitaire AB/FR, Covidien/ev3, Irvine, CA; Trevo Proview, Stryker, CA); (2) patients with occlusion of the anterior circulation large artery defined by digital subtraction angiography (DSA); (3) modified Rankin Scale (mRS) score before the index stroke ≤ 1; and (4) time from onset to puncture (OTP) < 12 h. The exclusion criteria were as follows: (1) intracranial hemorrhage defined in CT scan prior to MT; (2) Severe heart, liver, and renal insufficiency, or severe diabetes (blood glucose level > 22 mmol/L); (3) Coagulation dysfunction such as platelet count 100 × 10⁹/L; (4) Missing case data or imaging examination results or loss to follow-up. Our study protocol was approved by the human ethics committee of The Second Affiliated Hospital of Zhejiang University.

Cai L., Wang T., Chen A., Ling C., Xu J., Qian C, & Chen G. (2022). Safety and Efficacy of Tirofiban in Severe Ischemic Stroke Patients Undergoing Mechanical Thrombectomy. Journal of Cardiovascular Development and Disease, 9(11), 408.

+ Open protocol

+ Expand

Multimodal Stroke Thrombectomy Techniques

Check if the same lab product or an alternative is used in the 5 most similar protocols

All eligible patients underwent MT immediately after imaging and clinical assessment of indications according to current guidelines. Subjects who underwent MT employed stent retriever (Solitaire AB/FR, Covidien/ev3, Irvine, CA; Trevo Proview, Stryker, CA), aspiration device (Penumbra, Alameda, CA) as the first recanalization option according to protocol. For cases failed to first MT attempt, additional thrombectomy attempts and alternative rescue therapies were adopted at the discretion of the operator, including intra-arterial/intravenous tirofiban administration, intra-arterial thrombolysis (urokinase: increments of 100000 IU to a maximum dose of 1000000 IU, or rtPA: 5–30mg), balloon angioplasty and emergent stenting.

Huo X., Yang M., Ma N., Gao F., Mo D., Li X., Wang A., Wang Y, & Miao Z. (2020). Safety and Efficacy of Tirofiban During Mechanical Thrombectomy for Stroke Patients with Preceding Intravenous Thrombolysis. Clinical Interventions in Aging, 15, 1241-1248.

+ Open protocol

+ Expand

Thrombectomy Protocols for Acute Ischemic Stroke

Check if the same lab product or an alternative is used in the 5 most similar protocols

Intravenous thrombolysis (IVT) was introduced to AIS patients who were admitted within 4.5 hours from stroke onset. While, if IVT was contraindicated, EVT was performed directly. Stent retriever (Solitaire AB/FR, Covidien/ev3, Irvine, CA; Trevo Proview, Stryker, CA) or aspiration device (Penumbra, Alameda, CA) was introduced as the first recanalization attempt. Additional thrombectomy and alternative rescue therapies, (administration of tirofiban, balloon angioplasty, thrombolysis and rescuing stent) were adopted at the discretion of the operator.

Huo X., R.a.y.n.a.l.d., Sun X., Mo D., Gao F., Ma N., Wang Y., Wang Y, & Miao Z. (2021). Influence of coronavirus disease 2019 (COVID-19) on working flow, safety and efficacy outcome of mechanical thrombectomy for acute ischemic stroke with large vessel occlusion. Interventional Neuroradiology, 28(1), 58-64.

+ Open protocol

+ Expand

Mechanical Thrombectomy with Tirofiban in Acute Ischemic Stroke

Check if the same lab product or an alternative is used in the 5 most similar protocols

All enrolled patients were treated according to current guidelines for AIS and underwent MT employed second-generation stent-retriever devices (Solitaire AB/FR, Covidien/ev3, Irvine, CA; Trevo Proview, Stryker, CA). Alternative rescue therapies, including balloon angioplasty and rescuing stent, were determined by the operators during the procedure based on the characteristics of the lesion and access. Following thrombectomy, all patients underwent postprocedural computed tomography (CT) within 12–24 h, and the presence of hemorrhage on CT was determined and scored by a blinded neuroradiologist.
Tirofiban was considered for application in the following situations: (1) rescue treatment with emergency stenting and balloon angioplasty for residual artery stenosis or failed thrombectomy, (2) successful mechanical recanalization with ≥3 passes with stent retriever, (3) severe in situ atherosclerosis with high risk of early re-occlusion, and (4) other recanalization refractory conditions and presumed endothelial damage. Tirofiban was continuously given at a rate of 8 μg/kg·h after an intravenous bolus of 10 μg/kg if there was no evidence of ICH on immediate head CT after MT. Twenty-four hours later, dual antiplatelet therapy was given after ICH was ruled out by another head CT.

Cai L., Yu X., Yu J., Xu J., Xu L., Ling C., Lou M., Yu C, & Qian C. (2021). Can Tirofiban Improve the Outcome of Patients With Acute Ischemic Stroke: A Propensity Score Matching Analysis. Frontiers in Neurology, 12, 688019.

+ Open protocol

+ Expand

Mechanical Thrombectomy for Acute Ischemic Stroke

Check if the same lab product or an alternative is used in the 5 most similar protocols

We identified all patients who underwent MT using a stent retriever (Solitaire AB/FR, Covidien/ev3, Irvine, CA; Trevo Proview, Stryker, CA), Penumbra system (Penumbra, Alameda, CA), or both for acute ischemic stroke because of LVO between September 2010 and December 2015 and had the 3-month modified Rankin Scale score (mRS) available. This study was initiated by the Korea Health Technology R&D Project, and the study population was recruited from the cohorts prospectively registered in 16 participating comprehensive stroke centers. Tandem cervical ICA and intracranial large artery occlusions were included. Cervical ICA dissection was included, but intracranial artery dissection was excluded. Bilateral large artery occlusions was also excluded. Enrollment criteria were as follows: (1) age ≥18 years old, (2) initial National Institutes of Health Stroke Scale score (NIHSS) ≥4, (3) onset-to-puncture time ≤600 minutes, (4) mRS of 0 or 1 before qualifying stroke, (5) collateral grading on computed tomographic angiogram (CTA) assessable, (6) recanalization success or failure assessable, and (7) intracranial ICA or MCA-M1 occlusion documented during the endovascular therapy. The institutional review boards of all participating hospitals approved this study and waived the requirement for informed consent for study inclusion based on the retrospective study design.

Chang Y., Kim B.M., Bang O.Y., Baek J.H., Heo J.H., Nam H.S., Kim Y.D., Yoo J., Kim D.J., Jeon P., Baik S.K., Suh S.H., Lee K.Y., Kwak H.S., Roh H.G., Lee Y.J., Kim S.H., Ryu C.W., Ihn Y.K., Kim B., Jeon H.J., Kim J.W., Byun J.S., Suh S., Park J.J., Lee W.J., Roh J., Shin B.S, & Kim J.M. (2018). Rescue Stenting for Failed Mechanical Thrombectomy in Acute Ischemic Stroke: A Multicenter Experience. Stroke, 49(4).

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!